Richard M. Myers

Dr. Richard M. Myers received his B.S. in Biochemistry from the University of Alabama in 1976, his Ph.D. in Biochemistry from the University of California, Berkeley in 1982, and did his post-doctoral training at Harvard University. He joined the faculty of the UCSF Medical Center in 1985 moved to Stanford University in 1993, where he was Professor and Chair in the Department of Genetics, and Director of the Stanford Human Genome Center. In 2008, Dr. Myers became President, Science Director and a Faculty Investigator of the HudsonAlpha Institute for Biotechnology, a non-profit research and teaching enterprise in Huntsville, Alabama. His research uses genomics to study how genes and regulatory elements affect a variety of human traits, including neurodegenerative and neuropsychiatric disorders, cancer, diseases of the immune system, and childhood genetic disorders. Dr. Myers serves on several advisory panels and editorial boards for the U.S. National Institutes of Health and several universities. He is an Associate Editor of the journal Genome Research. He serves as a science advisor to Decheng Capital, Pfizer and several biotech companies. With Dr. Sara Marsal, he is co-founder and science advisor of IMIDomics, Inc.